OvaRex: Phase II

ALRXF reported that treatment with OvaRex induced anti-CA125 antibodies in

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE